Sep 23, 2026 9 0
Uploaded by Ezra
Favorite
Share
More Options
13
T-cell immune checkpoint inhibition plus hypomethylation for locally advanced HER2-negative breast cancer: a phase 2 neoadjuvant window trial of decitabine and pembrolizumab followed by standard neoadjuvant chemotherapy_Page 1

Open in WPS to view all 13 pages